结肠直肠癌的分子靶向治疗研究进展(6)
[8] de Gramont A, Van Cutsem E, Schmoll HJ, et al. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial [J]. Lancet Oncol, 2012, 13(12): 1225-1233.
[9] Van Cutsem E, Tabernero J, Lakomy R, et al. Addition of aflibercept to fluorouracil ......
您现在查看是摘要页,全文长 2717 字符。
[9] Van Cutsem E, Tabernero J, Lakomy R, et al. Addition of aflibercept to fluorouracil ......
您现在查看是摘要页,全文长 2717 字符。